Literature DB >> 24634213

Src family kinases promote silencing of ATR-Chk1 signaling in termination of DNA damage checkpoint.

Yasunori Fukumoto1, Mariko Morii, Takahito Miura, Sho Kubota, Kenichi Ishibashi, Takuya Honda, Aya Okamoto, Noritaka Yamaguchi, Atsushi Iwama, Yuji Nakayama, Naoto Yamaguchi.   

Abstract

The DNA damage checkpoint arrests cell cycle progression to allow time for repair. Once DNA repair is completed, checkpoint signaling is terminated. Currently little is known about the mechanism by which checkpoint signaling is terminated, and the disappearance of DNA lesions is considered to induce the end of checkpoint signaling; however, here we show that the termination of checkpoint signaling is an active process promoted by Src family tyrosine kinases. Inhibition of Src activity delays recovery from the G2 phase DNA damage checkpoint following DNA repair. Src activity is required for the termination of checkpoint signaling, and inhibition of Src activity induces persistent activation of ataxia telangiectasia mutated (ATM)- and Rad3-related (ATR) and Chk1 kinases. Src-dependent nuclear protein tyrosine phosphorylation and v-Src expression suppress the ATR-mediated Chk1 and Rad17 phosphorylation induced by DNA double strand breaks or DNA replication stress. Thus, Src family kinases promote checkpoint recovery through termination of ATR- and Chk1-dependent G2 DNA damage checkpoint. These results suggest a model according to which Src family kinases send a termination signal between the completion of DNA repair and the initiation of checkpoint termination.

Entities:  

Keywords:  Cell Cycle; Checkpoint Control; Checkpoint Recovery; DNA Damage; DNA Damage Response; Src

Mesh:

Substances:

Year:  2014        PMID: 24634213      PMCID: PMC4007429          DOI: 10.1074/jbc.M113.533752

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

1.  c-Src but not Fyn promotes proper spindle orientation in early prometaphase.

Authors:  Yuji Nakayama; Yuki Matsui; Yumi Takeda; Mai Okamoto; Kohei Abe; Yasunori Fukumoto; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

2.  Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrest.

Authors:  Atsushi Shibata; Olivia Barton; Angela T Noon; Kirsten Dahm; Dorothee Deckbar; Aaron A Goodarzi; Markus Löbrich; Penny A Jeggo
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

3.  The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association.

Authors:  Yuuki Obata; Yasunori Fukumoto; Yuji Nakayama; Takahisa Kuga; Naoshi Dohmae; Naoto Yamaguchi
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

4.  Activation of Src-like p56/p53lyn tyrosine kinase by ionizing radiation.

Authors:  S Kharbanda; Z M Yuan; E Rubin; R Weichselbaum; D Kufe
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

5.  The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.

Authors:  Remko Prevo; Emmanouil Fokas; Philip M Reaper; Peter A Charlton; John R Pollard; W Gillies McKenna; Ruth J Muschel; Thomas B Brunner
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

6.  Protein tyrosine kinase Lyn mediates apoptosis induced by topoisomerase II inhibitors in DT40 cells.

Authors:  A Maruo; I Oishi; K Sada; M Nomi; T Kurosaki; Y Minami; H Yamamura
Journal:  Int Immunol       Date:  1999-09       Impact factor: 4.823

7.  Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains.

Authors:  Chuen-Pei Ng; Hung Chiu Lee; Chung Wai Ho; Talha Arooz; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  J Biol Chem       Date:  2003-12-16       Impact factor: 5.157

8.  Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms.

Authors:  J D Bjorge; C Bellagamba; H C Cheng; A Tanaka; J H Wang; D J Fujita
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

9.  Nuclear localization of Lyn tyrosine kinase mediated by inhibition of its kinase activity.

Authors:  Kikuko Ikeda; Yuji Nakayama; Yuuki Togashi; Yuuki Obata; Takahisa Kuga; Kousuke Kasahara; Yasunori Fukumoto; Naoto Yamaguchi
Journal:  Exp Cell Res       Date:  2008-09-11       Impact factor: 3.905

10.  Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex.

Authors:  K E Adams; A L Medhurst; D A Dart; N D Lakin
Journal:  Oncogene       Date:  2006-02-13       Impact factor: 9.867

View more
  10 in total

1.  Activation of Lyn tyrosine kinase through decreased membrane cholesterol levels during a change in its membrane distribution upon cell detachment.

Authors:  Takao Morinaga; Kohei Abe; Yuji Nakayama; Noritaka Yamaguchi; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

2.  Attenuation of SRC Kinase Activity Augments PARP Inhibitor-mediated Synthetic Lethality in BRCA2-altered Prostate Tumors.

Authors:  Goutam Chakraborty; Nabeela Khan Patail; Rahim Hirani; Subhiksha Nandakumar; Ying Z Mazzu; Yuki Yoshikawa; Mohammad Atiq; Lina E Jehane; Konrad H Stopsack; Gwo-Shu Mary Lee; Wassim Abida; Michael J Morris; Lorelei A Mucci; Daniel Danila; Philip W Kantoff
Journal:  Clin Cancer Res       Date:  2020-12-17       Impact factor: 13.801

3.  v-Src Causes Chromosome Bridges in a Caffeine-Sensitive Manner by Generating DNA Damage.

Authors:  Masayoshi Ikeuchi; Yasunori Fukumoto; Takuya Honda; Takahisa Kuga; Youhei Saito; Naoto Yamaguchi; Yuji Nakayama
Journal:  Int J Mol Sci       Date:  2016-06-02       Impact factor: 5.923

4.  Small Molecule Supplements Improve Cultured Megakaryocyte Polyploidization by Modulating Multiple Cell Cycle Regulators.

Authors:  Xiaojing Zou; Mingyi Qu; Fang Fang; Zeng Fan; Lin Chen; Wen Yue; Xiaoyan Xie; Xuetao Pei
Journal:  Biomed Res Int       Date:  2017-10-19       Impact factor: 3.411

5.  The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.

Authors:  Silvia Grasso; Davide Cangelosi; Jennifer Chapelle; Melissa Alzona; Emilia Turco; Paola Defilippi; Giorgia Centonze; Alessia Lamolinara; Vincenzo Salemme; Costanza Angelini; Alessandro Morellato; Andrea Saglietto; Federico Tommaso Bianchi; Sara Cabodi; Iris Chiara Salaroglio; Federica Fusella; Marzia Ognibene; Manuela Iezzi; Annalisa Pezzolo; Valeria Poli; Ferdinando Di Cunto; Alessandra Eva; Chiara Riganti; Luigi Varesio
Journal:  Cell Death Differ       Date:  2019-07-08       Impact factor: 15.828

Review 6.  The Androgen Receptor and Its Crosstalk With the Src Kinase During Castrate-Resistant Prostate Cancer Progression.

Authors:  Lin Gao; Bo Han; Xuesen Dong
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

7.  Links between the unfolded protein response and the DNA damage response in hypoxia: a systematic review.

Authors:  Hannah Bolland; Tiffany S Ma; Syafiq Ramlee; Kristijan Ramadan; Ester M Hammond
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

Review 8.  Cross talk of tyrosine kinases with the DNA damage signaling pathways.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Nucleic Acids Res       Date:  2015-11-05       Impact factor: 16.971

9.  Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.

Authors:  Zhenhua Qi; Fang Yan; Dongtai Chen; Wei Xing; Qiang Li; Weian Zeng; Bingtian Bi; Jingdun Xie
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

10.  Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases.

Authors:  Samia Mohammed; Achraf A Shamseddine; Benjamin Newcomb; Ronald S Chavez; Tyler D Panzner; Allen H Lee; Daniel Canals; Chioma M Okeoma; Christopher J Clarke; Yusuf A Hannun
Journal:  Breast Cancer Res       Date:  2021-07-27       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.